BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xin L, Yang WF, Zhang HT, Li YF, Liu C. The mechanism study of lentiviral vector carrying methioninase enhances the sensitivity of drug-resistant gastric cancer cells to Cisplatin. Br J Cancer 2018;118:1189-99. [PMID: 29576621 DOI: 10.1038/s41416-018-0043-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Patrad E, Khalighfard S, Amiriani T, Khori V, Alizadeh AM. Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy. Cell Oncol (Dordr) 2022. [PMID: 36149600 DOI: 10.1007/s13402-022-00715-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Lv C, Ren C, Yu Y, Yin H, Huang C, Yang G, Hong Y. Wentilactone A Reverses the NF-κB/ECM1 Signaling-Induced Cisplatin Resistance through Inhibition of IKK/IκB in Ovarian Cancer Cells. Nutrients 2022;14:3790. [DOI: 10.3390/nu14183790] [Reference Citation Analysis]
3 Zhao B, Zhu W. Exosomal miRNA-455 from Bone Marrow Stromal Cells (BMSCs) Promotes Macrophage Phagocytosis and Restrains Progression of Gastric Cancer (GC). j biomater tissue eng 2022;12:558-63. [DOI: 10.1166/jbt.2022.2939] [Reference Citation Analysis]
4 He G, Ding J, Zhang Y, Cai M, Yang J, Cho WC, Zheng Y. microRNA-21: a key modulator in oncogenic viral infections. RNA Biol 2021;18:809-17. [PMID: 33499700 DOI: 10.1080/15476286.2021.1880756] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Zhao X, Hu GF, Shi YF, Xu W. Research Progress in microRNA-Based Therapy for Gastric Cancer. Onco Targets Ther 2019;12:11393-411. [PMID: 31920330 DOI: 10.2147/OTT.S221354] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
6 Lin X, Li S, Zhou C, Li R, Wang H, Luo W, Huang Y, Chen L, Cai J, Wang T, Zhang Q, Cao H, Wu X. Cisplatin induces chemoresistance through the PTGS2-mediated anti-apoptosis in gastric cancer. The International Journal of Biochemistry & Cell Biology 2019;116:105610. [DOI: 10.1016/j.biocel.2019.105610] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
7 Xin L, Zhou Q, Yuan YW, Zhou LQ, Liu L, Li SH, Liu C. METase/lncRNA HULC/FoxM1 reduced cisplatin resistance in gastric cancer by suppressing autophagy. J Cancer Res Clin Oncol 2019;145:2507-17. [PMID: 31485766 DOI: 10.1007/s00432-019-03015-w] [Cited by in Crossref: 35] [Cited by in F6Publishing: 42] [Article Influence: 8.8] [Reference Citation Analysis]
8 Hoffman RM, Miki K, Al-Refaie W, Xu M, Tan Y. Methioninase Gene Therapy. Methods Mol Biol 2019;1866:173-97. [PMID: 30725416 DOI: 10.1007/978-1-4939-8796-2_14] [Reference Citation Analysis]
9 Zhang H, Jiang H, Zhang H, Liu J, Hu X, Chen L. Ribophorin II potentiates P-glycoprotein- and ABCG2-mediated multidrug resistance via activating ERK pathway in gastric cancer. Int J Biol Macromol 2019;128:574-82. [PMID: 30710584 DOI: 10.1016/j.ijbiomac.2019.01.195] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]